# Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty

> **NCT00818493** · PHASE2 · COMPLETED · sponsor: **QRxPharma Inc.** · enrollment: 44 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Q8003 (morphine sulfate and oxycodone hydrochloride)
- **DRUG:** Low dose Q8003 (morphine sulfate and oxycodone hydrochloride)
- **DRUG:** Percocet (oxycodone and acetaminophen)

## Key facts

- **NCT ID:** NCT00818493
- **Lead sponsor:** QRxPharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2012-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00818493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00818493, "Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00818493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*